Advertisement

Author: Richard Hefter

Impressive Action in BMY

Bristol-Myers Squibb (BMY) has climbed to a new recovery and new 2 3/4-year high at 27.26 (so far) today, which has triggered new projections into the 28.00-29.00 target zone in the upcoming weeks and months. The BMY situation...

Read More

SIGN UP TO NEWSLETTER

Join our mailing list to receive the latest news and updates from our team.